guest ::
| Home > Publications database > Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients. > print |
| Home > Publications database > Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients. > print |
| 001 | 130420 | ||
| 005 | 20240228143432.0 | ||
| 024 | 7 | _ | |a 10.1093/carcin/bgw080 |2 doi |
| 024 | 7 | _ | |a pmid:27497070 |2 pmid |
| 024 | 7 | _ | |a 0143-3334 |2 ISSN |
| 024 | 7 | _ | |a 1460-2180 |2 ISSN |
| 037 | _ | _ | |a DKFZ-2017-05499 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Rizzato, Cosmeri |0 P:(DE-HGF)0 |b 0 |e First author |
| 245 | _ | _ | |a Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients. |
| 260 | _ | _ | |a Oxford |c 2016 |b Oxford Univ. Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1522227525_30780 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Germline genetic variability might contribute, at least partially, to the survival of pancreatic ductal adenocarcinoma (PDAC) patients. Two recently performed genome-wide association studies (GWAS) on PDAC overall survival (OS) suggested (P < 10(-5)) the association between 30 genomic regions and PDAC OS. With the aim to highlight the true associations within these regions, we analyzed 44 single-nucleotide polymorphisms (SNPs) in the 30 candidate regions in 1722 PDAC patients within the PANcreatic Disease ReseArch (PANDoRA) consortium. We observed statistically significant associations for five of the selected regions. One association in the CTNNA2 gene on chromosome 2p12 [rs1567532, hazard ratio (HR) = 1.75, 95% confidence interval (CI) 1.19-2.58, P = 0.005 for homozygotes for the minor allele] and one in the last intron of the RUNX2 gene on chromosome 6p21 (rs12209785, HR = 0.88, 95% CI 0.80-0.98, P = 0.014 for heterozygotes) are of particular relevance. These loci do not coincide with those that showed the strongest associations in the previous GWAS. In silico analysis strongly suggested a possible mechanistic link between these two SNPs and pancreatic cancer survival. Functional studies are warranted to confirm the link between these genes (or other genes mapping in those regions) and PDAC prognosis in order to understand whether these variants may have the potential to impact treatment decisions and design of clinical trials. |
| 536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a CTNNA2 protein, human |2 NLM Chemicals |
| 650 | _ | 7 | |a Core Binding Factor Alpha 1 Subunit |2 NLM Chemicals |
| 650 | _ | 7 | |a RUNX2 protein, human |2 NLM Chemicals |
| 650 | _ | 7 | |a alpha Catenin |2 NLM Chemicals |
| 700 | 1 | _ | |a Campa, Daniele |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Talar-Wojnarowska, Renata |b 2 |
| 700 | 1 | _ | |a Halloran, Christopher |b 3 |
| 700 | 1 | _ | |a Kupcinskas, Juozas |b 4 |
| 700 | 1 | _ | |a Butturini, Giovanni |b 5 |
| 700 | 1 | _ | |a Mohelníková-Duchoňová, Beatrice |b 6 |
| 700 | 1 | _ | |a Sperti, Cosimo |b 7 |
| 700 | 1 | _ | |a Tjaden, Christine |b 8 |
| 700 | 1 | _ | |a Ghaneh, Paula |b 9 |
| 700 | 1 | _ | |a Hackert, Thilo |b 10 |
| 700 | 1 | _ | |a Funel, Niccola |b 11 |
| 700 | 1 | _ | |a Giese, Nathalia |b 12 |
| 700 | 1 | _ | |a Tavano, Francesca |b 13 |
| 700 | 1 | _ | |a Pezzilli, Raffaele |b 14 |
| 700 | 1 | _ | |a Pedata, Mariangela |b 15 |
| 700 | 1 | _ | |a Pasquali, Claudio |b 16 |
| 700 | 1 | _ | |a Gazouli, Maria |b 17 |
| 700 | 1 | _ | |a Mambrini, Andrea |b 18 |
| 700 | 1 | _ | |a Souček, Pavel |b 19 |
| 700 | 1 | _ | |a di Sebastiano, Pierluigi |b 20 |
| 700 | 1 | _ | |a Capurso, Gabriele |b 21 |
| 700 | 1 | _ | |a Cantore, Maurizio |b 22 |
| 700 | 1 | _ | |a Oliverius, Martin |b 23 |
| 700 | 1 | _ | |a Offringa, Rienk |0 P:(DE-He78)81ae96953d6149e4307057d71a190019 |b 24 |u dkfz |
| 700 | 1 | _ | |a Małecka-Panas, Ewa |b 25 |
| 700 | 1 | _ | |a Strobel, Oliver |b 26 |
| 700 | 1 | _ | |a Scarpa, Aldo |b 27 |
| 700 | 1 | _ | |a Canzian, Federico |0 P:(DE-He78)5323704270b6393dcea70186ffd86bca |b 28 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1093/carcin/bgw080 |g Vol. 37, no. 10, p. 957 - 964 |0 PERI:(DE-600)1474206-8 |n 10 |p 957 - 964 |t Carcinogenesis |v 37 |y 2016 |x 1460-2180 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:130420 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 24 |6 P:(DE-He78)81ae96953d6149e4307057d71a190019 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 28 |6 P:(DE-He78)5323704270b6393dcea70186ffd86bca |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2016 |
| 915 | _ | _ | |a Allianz-Lizenz / DFG |0 StatID:(DE-HGF)0400 |2 StatID |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CARCINOGENESIS : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-He78)C055-20160331 |k C055 |l Genomische Epidemiologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)G180-20160331 |k G180 |l Molekulare Grundlagen Gastrointestinaler Tumoren |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C055-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G180-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|